Harris NA Concentrated Equity Class B

Profile

This strategy mainly invests in (certificates of) shares of companies listed on North American stock exchanges with a market capitalization of at least $ 5 billion at the time of purchase. The investment policy of the strategy is aimed at putting together a portfolio based on a fundamental, bottom-up stock selection process. Harris NA Concentrated Equity focuses on realizing long-term value growth. The Fund is actively managed.

Management team

Harris Associates L.P.

Performance per 2018-07-31

Slide to see more
  Fund
1 month 3.5 %
3 months 11.6 %
This year 9.7 %
2017 0.9 %
1 year (on annual basis) 10.8 %
Since inception (on annual basis) i 6.2 %
More information can be found on the documents page of this fund

Key figures

Slide to see more
Total fund size
EUR 105.61 M 2018-07-31
Share class size
EUR 71.13 M 2018-07-31
Number of shares
2,642,851 2018-07-31
Net Asset Value i
EUR 27.16 2018-08-14
Transaction price i
EUR 23.91 2017-11-29
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Performance per 2018-07-31

Slide to see more
  Fund
1 month 3.5 %
3 months 11.6 %
This year 9.7 %
2017 0.9 %
1 year (on annual basis) 10.8 %
Since inception (on annual basis) i 6.2 %

Dividends

Slide to see more
Distributing
No
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Top 10 holdings (2018-07-31)

5.0 %
ALPHABET INC-CL C
4.2 %
CHARTER COMMUNICATIONS INC-A
4.2 %
WELLS FARGO & CO
4.0 %
HCA HEALTHCARE INC
4.0 %
AMERICAN INTERNATIONAL GROUP
3.3 %
ORACLE CORP
3.3 %
CITIGROUP INC
3.2 %
GENERAL MOTORS CO
3.0 %
NETFLIX INC
2.9 %
MOODY'S CORP
Totaal
37.3 %
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Ongoing charges

Slide to see more
Ongoing charges last financial year i
0.76 %
The Ongoing Charges Figure is annualized.

Other costs

Slide to see more
Upward swing factor i
0.15 %
Downward swing factor i
0.10 %
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Share class details

Slide to see more
Share class
B i
Investor type
Institutional & Private
Distributing
No
Benchmark i
MSCI North American Index
Duration hedged
No
Investment category
Other
Universum
North American shares
Inception date
2017-05-10
Domicile
The Netherlands
May be offered to all investors in
The Netherlands
UCITS status i
No
Status
Open-end i
Base currency
EUR
Share class currency
EUR
Administrator
BNP Paribas Securities Services S.C.A.
Auditor
Ernst & Young Accountants LLP
Transfer agent
F. van Lanschot Bankiers N.V.
Management company
Kempen Capital Management N.V.
Custodian
BNP Paribas Securities Services S.C.A.

Tradability

Slide to see more
Listed
no
Subscription/Redemption Frequency
Daily
ISIN i
NL0012294532
Harris NA Concentrated Equity will only be available for orders submitted via the Transfer Agent platform of F. van Lanschot Bankiers N.V. Participations will only be available for distributors who submit orders on behalf of their clients, and who have been selected by the management company.
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Read more information about Kempen Capital Management N.V. on this site and find also more information on BNP Paribas Securities Services S.C.A.

Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

KCM Vision

Kempen Capital Management is an asset manager with a long-term investment approach. We strongly believe in engaged shareholdership that benefits all stakeholders. As a long-term responsible investor, we firmly believe that active ownership and shareholder engagement contribute to positive change across the board.

Our KCM wide approach to responsible investment

To put our vision into action we engage with our investment targets on a wide array of strategic, financial, environmental, social and governance (ESG) topics. Our long-term investment worldview paired with thorough analysis and an experienced and diverse ESG team allow us to use both voting and engagement as means to consistently encourage positive change. Through this process of constructive engagement, we are able to contribute to the development of principles and standards of corporate responsibility within companies that we invest in. Our full voting records are available here.

Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.